Doug Kelly MD

Doug Kelly has worked with the partners of Alloy Ventures since 1993 and was a founding member of the firm. He currently focuses on investments in medical device companies.

Trained as a physician, Doug is a long-time venture investor with 20 years of experience in bridging the needs of the business and medical communities with novel applications of technology to create world-class companies. Prior to joining Alloy Ventures, he worked for two European venture capital firms, in business development at Ligand Pharmaceuticals, and as an independent consultant. Additionally, Doug teaches “Business 16 Financing The Startup” at Stanford University. Doug received a BA in Biochemistry and Cell Biology from the University of California at San Diego (1983), an MD from the Albert Einstein College of Medicine in 1988, and an MBA from Stanford University (1990).

Doug also serves on the board of directors for Restoration Robotics. Doug has invested in many leading medical device and biotech companies, and previously served on the boards of Sapient Health Network (acquired by WebMD/Healtheon in 1999), Camitro (acquired by Arqule in 2001), Fusion Medical (acquired by Baxter in 2002), Integrated Biosystems (acquired by Stedim SA in 2004), Adiana (acquired by Cytyc/Hologic in 2007), Pharsight (acquired by Tripos in 2008), Barrx Medical (acquired by Covidien in January 2012), Cameron Health (acquired by Boston Scientific in June 2012), Crux Biomedical (acquired by Volcano Corp. in December 2012), and CoAlign Innovations (acquired by Stryker in March, 2014).